RMD
ResMed Inc.NYSEResearch view
Healthcare · Surgical & Medical Instruments & Apparatus · Large-cap · SEC EDGAR FY 2026-06-30
Price history
Chart: TradingView’s own feed · page prices: 1D EOD🔒 Click to interact · scroll moves the page
Snapshot
SEC EDGAR · FY 2026-06-30SectorHealthcare
Market Cap$31.5B
Enterprise Value$30.4B
Income$1.5B
Sales$5.7B
Book/sh$45.65
Cash/sh$10.19
Dividend TTM$2.40
Payout23%
Employees—
IPO—
Quick Ratio2.42
Current Ratio3.10
Debt/Eq0.06
EPS (ttm)$10.43
EPS this Y9.7%
EPS past 3/5Y19.6%
Sales past 3/5Y10.2%
EPS Y/Y TTM9.7%
Sales Y/Y TTM9.9%
Shs Outstand144.25M
ROA17.0%
ROE23.1%
ROIC27.1%
Gross Margin61.1%
Oper. Margin33.4%
Profit Margin26.9%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$3.6B
2022
$4.2B
2023
$4.7B
2024
$5.1B
2025
$5.7B
2026
Financials — annual
SEC EDGAR · last 5 FY · tap a row to explain it| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $3.6B | $4.2B | $4.7B | $5.1B | $5.7B |
| Gross Profit | $2.0B | $2.4B | $2.7B | $3.1B | $3.5B |
| Operating Income | $1.0B | $1.1B | $1.3B | $1.7B | $1.9B |
| Net Income | $779.4M | $897.6M | $1.0B | $1.4B | $1.5B |
| Diluted EPS | $5.30 | $6.09 | $6.92 | $9.51 | $10.43 |
| Operating Cash Flow | $351.1M | $693.3M | $1.4B | $1.8B | $1.8B |
| Free Cash Flow | $216.3M | $573.6M | $1.3B | $1.7B | $1.6B |
Deep dive
Computed from the SEC EDGAR multi-year statementsOperating leverage — margins
GrossOperatingNet
FY26 cash-flow waterfall
Capital-light: capex is $156.3M against $1.8B operating cash
COMMUNITY · $RMD0 theses
POST YOUR TAKE →Related Stocks
Click to exploreSame Industry · Surgical & Medical Instruments & Apparatus
Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.